Financing, Equity Capital Markets

Akebia Therapeutics, Inc.

05/20
|
$132.0 Million
Piper Sandler served as bookrunner for Akebia Therapeutics on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma